Home » Newsletters » BioWorld Asia

BioWorld Asia

Dec. 12, 2001

View Archived Issues

KS Biomedix Drops Development Of Lead Osteoarthritis Compound

EU Agrees To $1B In Support Of Genome, Biotech Research

Surprise Discovery Shows Cytokines Can Help Repair DNA

Teva Invests $10M In Proneuron, Buys Into Expanded Use Of COP-1

Genome Express Raises $11M To Advance Work In Genomics

Abingworth Management Closes Life Science Fund At US$225M

Phytopharm Gets Good Results In Phase II Obesity Study Of P57

Medigene Seeks First Approval, Files Application For Leuprogel

Cytos, Millennium Enter Orphan Target Discovery Collaboration

Other News To Note

Swedish Research Council Backs Therapeutic Cloning

ExonHit, BioMirieux-Pierre Fabre Form Cancer Research Alliance

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.